Skip to content

Lime Powder Regimen in Healthy Volunteers

Medicinal Effect of Lime Powder Regimen in HK-2 Cell Exposed to Lithogenic Crystals and Its Citraturic and Antioxidative Responses in Healthy Volunteers

Status
UNKNOWN
Phases
Phase 1
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01273025
Acronym
LimePKphase1
Enrollment
15
Registered
2011-01-10
Start date
2010-12-31
Completion date
2011-03-31
Last updated
2011-01-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Kidney Stone, Oxidative Stress

Keywords

pharmacokinetic, lime powder regimen, kidney stone, Oxidative stress

Brief summary

The study aims to investigate the pharmacokinetic parameters and its antioxidative effects in Thai healthy men.

Interventions

DIETARY_SUPPLEMENTLime powder regime

1 sachet of lime powder regimen with 200 ml of water

Sponsors

Chulalongkorn University
Lead SponsorOTHER

Study design

Allocation
NON_RANDOMIZED
Intervention model
SINGLE_GROUP
Primary purpose
BASIC_SCIENCE
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 45 Years
Healthy volunteers
Yes

Inclusion criteria

* Thai healthy male or female aged 18-45 years old * BMI 18-25 kg/m2 * Normal medical history, physical examination and vital signs * Normal screening laboratories * no history of drug allergies * Willingness to take part in the study and provide informed consent

Exclusion criteria

* History of GI, liver, kidney, allergic disease or any other disease that may interfere with the bioavailability of lime powder regimen * History of alcohol or drug abuse * Heavy smoking * Receive any medication within 14 days prior to the study day

Design outcomes

Primary

MeasureTime frameDescription
The pharmacokinetic parameters of plasma and urine citrate6 monthsThe pharmacokinetic parameters of plasma and urine citrate incluiding Cmax, Tmax, Half life, AUC, and elimination rate constant

Countries

Thailand

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026